Table 2.
Basic demographic and clinical characteristics of the subjects
| Characteristics | Non‐EH (n = 48) | EH (n = 48) | χ 2/t | P‐value |
|---|---|---|---|---|
| Drinking (Y/N) | 6/42 | 10/38 | 1.20 | .273 |
| Smoking (Y/N) | 7/41 | 11/37 | 1.09 | .296 |
| Sex (F/M) | 30/18 | 30/18 | 0 | 1 |
| Age (year) | 55.31 ± 9.76 | 55.58 ± 9.67 | 0.14 | .892 |
| BMI (Kg/m2) | 23.03 ± 2.68 | 23.89 ± 2.69 | 1.55 | .125 |
| ALT (IU/L) | 23.10 ± 14.12 | 24.34 ± 16.08 | 0.40 | .691 |
| AST (IU/L) | 23.88 ± 6.38 | 23.98 ± 7.44 | 0.07 | .942 |
| Scr (μmol/L) | 78.88 ± 16.52 | 76.02 ± 21.31 | −7.28 | .467 |
| BUN (μmol/L) | 5.28 ± 1.10 | 5.22 ± 1.10 | −0.27 | .790 |
| BUA (μmol/L) | 356.29 ± 66.08 | 351.02 ± 79.83 | −0.35 | .726 |
| Glu (mmol/L) | 5.06 ± 0.71 | 5.25 ± 0.75 | 1.27 | .207 |
| RBC | 4.59 ± 0.40 | 4.65 ± 0.49 | 0.640 | .527 |
| Lym | 2.17 ± 0.58 | 2.13 ± 0.56 | −0.33 | .746 |
| Mono | 0.36 ± 0.15 | 0.37 ± 0.15 | 0.42 | .676 |
| Neut | 3.52 ± 1.16 | 3.72 ± 1.39 | 0.80 | .428 |
| WBC | 6.09 ± 1.52 | 6.36 ± 1.63 | 0.84 | .402 |
| LDL (mmol/L) | 2.88 ± 0.85 | 2.77 ± 0.64 | −0.69 | .490 |
| TG (mmol/L) | 1.65 ± 0.73 | 1.45 ± 0.55 | −1.52 | .132 |
| HDL (mmol/L) | 1.41 ± 0.31 | 1.31 ± 0.27 | −1.75 | .084 |
| TC (mmol/L) | 5.29 ± 0.90 | 5.18 ± 0.75 | −0.67 | .507 |
P‐value less than 0.05 is marked with *.
Abbreviations: ALT, alanine aminotransferase; AST, glutamic oxalacetic transaminase; BMI, body mass index; BUA, blood uric acid; BUN, blood urea nitrogen; Glu, blood glucose; HDL, high‐density lipoprotein; LDL, low density lipoprotein; Lym, lymphocyte ratio; Monor, monocyte ratio; Neut, neutrophil ratio; RBC, Red blood cell; Scr, serum creatinine; TC, total cholesterol; TG, triglycerdes; WBC, White blood cell.